Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Petr, Kessler"'
Autor:
Viera Sandecka, Tereza Popkova, Martin Stork, Vladimir Maisnar, Jiri Minarik, Alexandra Jungova, Petr Pavlicek, Lukas Stejskal, Lenka Pospisilova, Adriana Heindorfer, Jarmila Obernauerova, Evzen Gregora, Michal Sykora, Jana Ullrychova, Marek Wrobel, Petr Kessler, Tomas Jelinek, Peter Kunovszki, Sacheeta Bathija, Blanca Gros, Sabine Wilbertz, Qian Cai, Annette Lam, Ivan Spicka
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Smoldering multiple myeloma (SMM) is an asymptomatic precursor to active multiple myeloma (MM). The aim of this study was to report clinical characteristics and outcomes of patients with SMM stratified based on their risk of progression to M
Externí odkaz:
https://doaj.org/article/ac4fa0e66df54bf9a47e4350692f9954
Autor:
Erika Tarasco, Anne Sophie vonKrogh, Radomira Hrdlickova, Thomas R. Braschler, Teresa Iwaniec, Paul N. Knöbl, Eriko Hamada, Oleg Pikovsky, Stefan Farese, Odit Gutwein, Petr Kessler, Nina H. Schultz, Charis vonAuer, Jerzy Windyga, Kenneth Friedman, Ingrid Hrachovinova, James N. George, Masanori Matsumoto, Reinhard Schneppenheim, Bernhard Lämmle, Johanna Anna Kremer Hovinga
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 7, Pp n/a-n/a (2022)
Abstract Introduction Severe COVID‐19 is associated with an important increase of von Willebrand factor and mild lowering of ADAMTS13 activity that may, in the presence of a strong inflammatory reaction, increase the risk of acute thrombotic thromb
Externí odkaz:
https://doaj.org/article/b0ec99487a444cfaa49783a970f5fc28
Autor:
Jiri Minarik, Tomas Pika, Jakub Radocha, Alexandra Jungova, Jan Straub, Tomas Jelinek, Ludek Pour, Petr Pavlicek, Martin Mistrik, Lucie Brozova, Petra Krhovska, Katerina Machalkova, Pavel Jindra, Ivan Spicka, Hana Plonkova, Martin Stork, Jaroslav Bacovsky, Lenka Capkova, Michal Sykora, Petr Kessler, Lukas Stejskal, Adriana Heindorfer, Jana Ullrychova, Tomas Skacel, Vladimir Maisnar, Roman Hajek
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background We have performed a head to head comparison of all-oral triplet combination of ixazomib, lenalidomide and dexamethasone (IRD) versus lenalidomide and dexamethasone (RD) in patients with relapsed and refractory multiple myeloma (RR
Externí odkaz:
https://doaj.org/article/f4b149c2be57476793d1f90b53292d39
Autor:
Michal Sýkora, Lukas Stejskal, Alexandra Jungova, Vladimir Maisnar, Petr Kessler, Viera Sandecká, Jana Ullrychova, Adriana Heindorfer, Luděk Pour, Tomas Pika, Jan Straub, Martin Stork, Jiří Minařík, Lucie Brožová, Roman Hájek, Ivan Spicka, Tomas Jelinek, Petr Pavlicek, David Starostka, Sabina Ševčíková, Jakub Radocha, Marek Wrobel
Publikováno v:
European Journal of Haematology. 107:466-474
Objectives This study compared the use of bortezomib in different combination regimens in newly diagnosed multiple myeloma (NDMM) patients who were transplant ineligible. Patients and methods We analyzed data from the Registry of Monoclonal Gammopath
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e1c1a0103ebd62cfdd0ad071e031465
https://doi.org/10.1111/ejh.13683
https://doi.org/10.1111/ejh.13683
Autor:
Viera SANDECKA, Luděk POUR, Ivan ŠPIČKA, Jiří MINAŘÍK, Jakub RADOCHA, Tomáš JELÍNEK, Petr PAVLÍČEK, Alexandra JUNGOVÁ, Petr KESSLER, Marek WRÓBEL, Martin ŠTORK, Jan ŠTRAUB, Tomáš PIKA, Lenka ČÁPKOVÁ, Sabina ŠEVČÍKOVÁ, Vladimír MAISNAR, Roman HÁJEK
Publikováno v:
Neoplasma. 69(6)
We assessed the outcomes of pomalidomide and dexamethasone treatment in relapsed/refractory multiple myeloma (RRMM) patients with ≥1 prior line of therapy. We analyzed the data of all RRMM patients treated with pomalidomide and dexamethasone at nin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0549b45be2adbb252d16072e7e0e3d59
https://pubmed.ncbi.nlm.nih.gov/36591805
https://pubmed.ncbi.nlm.nih.gov/36591805
Autor:
Viera Sandecka, Tereza Popkova, Martin Stork, Vladimir Maisnar, Jiri Minarik, Alexandra Jungova, Petr Pavlicek, Lukas Stejskal, Lenka Pospisilova, Adriana Heindorfer, Jarmila Obernauerova, Evzen Gregora, Michal Sykora, Jana Ullrychova, Marek Wrobel, Petr Kessler, Hana Lukesova, Tomas Jelinek, Peter Kunovszki, Sacheeta Bathija, Blanca Gros Otero, Sabine Wilbertz, Qian Cai, Annette Lam, Ivan Špička
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S132-S133
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89e0895d5f0cebb02a2b564c60820172
https://doi.org/10.1016/s2152-2650(22)00507-9
https://doi.org/10.1016/s2152-2650(22)00507-9
Autor:
Jiri Minarik, Petr Pavlicek, Ludek Pour, Tomas Pika, Vladimir Maisnar, Ivan Spicka, Jiri Jarkovsky, Marta Krejci, Jaroslav Bacovsky, Jakub Radocha, Jan Straub, Petr Kessler, Marek Wrobel, Lenka Walterova, Michal Sykora, Jarmila Obernauerova, Lucie Brozova, Evzen Gregora, Dagmar Adamova, Jaromir Gumulec, Zdenek Adam, Vlastimil Scudla, Roman Hajek, Czech Myeloma Group
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0123866 (2015)
OBJECTIVE:Subcutaneous (SC) application of bortezomib has been recently introduced as a new application route in multiple myeloma (MM) patients. We performed an analysis to compare the outcomes of bortezomib-based therapy in multiple myeloma (MM) pat
Externí odkaz:
https://doaj.org/article/781e01a2fb62439984783e51c9bbd51c
Autor:
Bohumil, Seifert, Martin, Balík, Václava, Bártů, Ludmila, Bezdíčková, Vladimír, Černý, Ivana, Čierná-Peterová, Jozef, Čupka, Pavel, Dlouhý, David, Halata, Igor, Karen, Petr, Kessler, Vladimír, Koblížek, Norbert, Král, Tomáš, Kvasnička, Jan, Kvasnička, Cyril, Mucha, Miroslav, Penka, Štěpán, Svačina, Jana, Šeblová, Martin, Špaček, Milan, Trojánek
Publikováno v:
Casopis lekaru ceskych. 160(4)
There is insufficient evidence from medical studies for clinical approaches to patients with COVID-19 in primary care. Patients often urge the therapeutic use and preventive administration of various medicines, often controlled by studies insufficien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2b9299ae187195ad60d82c6791fd5b26
https://pubmed.ncbi.nlm.nih.gov/34416813
https://pubmed.ncbi.nlm.nih.gov/34416813
Autor:
Alexandra Jungova, Michal Sykora, Ivan Spicka, Luděk Pour, Jana Ullrychova, Roman Hájek, Jarmila Obernauerova, Petr Kessler, Vladimir Maisnar, Jiri Minarik, Peter Mikula, Tomas Jelinek, Petr Pavlicek, Lukas Stejskal, Adriana Heindorfer, Marek Wrobel, Jakub Radocha
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia
Background COVID-19 disease caused by SARS-CoV-2 coronavirus has affected millions of people worldwide. The mortality of this infection varies with age and comorbidities up to more than 10% in very elderly population. The aim of our study was to dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c02359d9313f9d077d0481561a3a4a0f
https://doi.org/10.1016/s2152-2650(21)02120-0
https://doi.org/10.1016/s2152-2650(21)02120-0
Autor:
Petr Kessler, Frantisek Sedlak, Jana Ullrychova, Roman Hájek, Adriana Heindorfer, Petr Pavlicek, Tereza Popkova, Michal Sykora, Martin Stork, Peter Mikula, Vladimir Maisnar, Ivan Spicka, Tomas Jelinek, Alexandra Jungova, Marek Wrobel, Jakub Radocha, Ludek Pour, Jiri Minarik, Petra Krhovska, Lucie Brozova
Publikováno v:
International journal of laboratory hematology. 43(5)
The definition of complete disease response (CR) in multiple myeloma (MM) continues to be reevaluated. The last widely accepted model of response assessment was proposed by the International Myeloma Working Group (IMWG) in 2016.1 Urine immunofixation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3458117a873d32f9e265fcc780c682f6
https://pubmed.ncbi.nlm.nih.gov/31010846
https://pubmed.ncbi.nlm.nih.gov/31010846